INOVIO to Participate in Upcoming Scientific Conference
PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conference:
-
Presentation:Next Gen Protein Replacement Therapeutics: DNA-Encoded Protein (DPROT) Technology Demonstrates in vivo Production of Functional FVIII in Mouse Model
Date:Wednesday, April 22
Time:9:45 AM MYT
-
Poster Presentation:FVIII Expression Via Non-viral Vector DNA Medicine Platform Results in Efficacious Levels of FVIII Protein and Correction of the Bleeding Phenotype in Hemophilia A Mice
Date:Wednesday, April 22
Time: 10:45 AM MYT
Available abstracts will be shared on INOVIO's website following presentations.
SOURCE INOVIO Pharmaceuticals, Inc.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Price Crashes Again – Why Some Analysts See This BTC Dip as an Opportunity

Raoul Pal Says Only Three Blockchains Held Strong During the Crypto Crash

Quantum Threat Forces Crypto Industry Into Defense Mode
Why Is James Wynn Intentionally Trading at a Loss?

